Subarachnoid hemorrhage (SAH), which occurs due to rupture of an intracranial aneurysm, is associated with significant mortality and long-term morbidity among survivors. SAH leads to early brain injury, especially neurovascular injuries, within the first 72 hours after SAH. Osteopontin (OPN) is an extracellular matrix protein that can interact with cell surface integrin receptors especially avP3 through its arginine-glycineaspartate (RGD) sequence and has been implicated in promoting cell survival, proliferation and reductions in cellular apoptosis. Recent studies from our laboratory and others have demonstrated the neurovascular protective effects of intracerebroventricular administration of recombinant osteopontin (rOPN) in various preclinical stroke models, which makes rOPN an attractive candidate for neurovascular protection. However, intracerebroventricular route is not translational; therefore, we propose to administer rOPN intranasally, which is an established, safe, and non-invasive method. Our central hypothesis is that intranasal administration of rOPN will provide neurovascular protection against early brain injury after SAH by preservation of smooth muscle phenotypes and stabilization of the BBB via integrin receptor signaling pathways. In addition, we propose that ICH and TBI cause similar expanded neurovascular injury, and rOPN will provide similar neurovascular protection to ICH and TBI. We propose three specific aims to address our hypothesis.
Aim 1 will determine the neurovascular protective effect of intranasal rOPN administration after SAH.
Aim 2 will determine the mechanisms of neurovascular protection by rOPN after SAH.
Aim 3 will determine a broad neurovascular protection of intranasal application of rOPN after ICH and TBI. Our specific hypothesis is that rOPN will offer similar neurovascular protection by preserving smooth muscle phenotypes, stabilizing BBB and reducing brain edema, to improve long term neurological and neurobehavioral functional outcomes. The long-term goal of this proposal is to provide a basis for clinical translation of rOPN as an effective therapeutic option to protect against the expanded neurovascular injuries in patients after SAH and to improve overall patient outcomes in the long-term.
Osteopontin is a protein whose level increases upon brain injury and protects brain cells. This project intends to establish a clinically relevant intranasal-drop application of osteopontin and test its brain protective effect and mechanisms.
|Pearce, William J (2018) For myosin light chain phosphatase, a very small subunit can make very big differences in the heart. Am J Physiol Heart Circ Physiol 314:H1157-H1159|
|Tong, Lu-Sha; Guo, Zhen-Ni; Ou, Yi-Bo et al. (2018) Cerebral venous collaterals: A new fort for fighting ischemic stroke? Prog Neurobiol 163-164:172-193|
|Pearce, William J (2018) Fetal Cerebrovascular Maturation: Effects of Hypoxia. Semin Pediatr Neurol 28:17-28|
|Pearce, W J (2018) A path well travelled may lead to better stroke recovery. Acta Physiol (Oxf) 223:e13061|
|Lu, Tai; Wang, Zhong; Prativa, Sherchan et al. (2018) Macrophage stimulating protein preserves blood brain barrier integrity after intracerebral hemorrhage through recepteur d'origine nantais dependent GAB1/Src/?-catenin pathway activation in a mouse model. J Neurochem :|
|Wu, Guangyong; McBride, Devin W; Zhang, John H (2018) Axl activation attenuates neuroinflammation by inhibiting the TLR/TRAF/NF-?B pathway after MCAO in rats. Neurobiol Dis 110:59-67|
|Xie, Zhiyi; Enkhjargal, Budbazar; Wu, Lingyun et al. (2018) Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats. Neuropharmacology 128:142-151|
|Zhu, Qiquan; Enkhjargal, Budbazar; Huang, Lei et al. (2018) Aggf1 attenuates neuroinflammation and BBB disruption via PI3K/Akt/NF-?B pathway after subarachnoid hemorrhage in rats. J Neuroinflammation 15:178|
|Wang, Yuechun; Sherchan, Prativa; Huang, Lei et al. (2018) Multiple mechanisms underlying neuroprotection by secretory phospholipase A2 preconditioning in a surgically induced brain injury rat model. Exp Neurol 300:30-40|
|Zhao, Lianhua; Chen, Shengpan; Sherchan, Prativa et al. (2018) Recombinant CTRP9 administration attenuates neuroinflammation via activating adiponectin receptor 1 after intracerebral hemorrhage in mice. J Neuroinflammation 15:215|
Showing the most recent 10 out of 68 publications